期刊文献+

离子液体敏化分光光度法测定依巴斯汀片中依巴斯汀含量

Determination of ebastine in ebastine tablet by ionic liquid sensitized spectrophotometry*
原文传递
导出
摘要 目的:建立一种测定依巴斯汀含量的新方法。方法:用光谱法研究依巴斯汀、水杨基荧光酮及1-丁基-3-甲基咪唑四氟硼酸盐(C4)间的相互作用。利用在pH6.5的醋酸缓冲体系中,依巴斯汀与水杨基荧光酮反应能形成稳定的化合物,且C4离子液体对其具有增敏作用,该物质在560 nm波长处有最大吸收,且其吸光度与依巴斯汀浓度在一定范围内存在定量关系,建立了测定依巴斯汀含量的新方法。结果:在优化条件下,线性方程为:A=0.029+0.005C(C,μg.mL-1),r=0.9995,检出限为0.96μg.mL-1(S/N=3),线性范围为2.5~20.0μg.mL-1,回收率为96.1%~106.4%。结论:本法快速准确,简便易行,适用于依巴斯汀片中依巴斯汀含量的测定。 Objective:To establish a method for the determination of ebastine (EBS). Method:The interaction of EBS, salicyl fluorine (SAF) and 1 - butyl - 3 - methylimidazolium tetrafluoroborate ( C4 ) was studied by spectro-photometry. It showed a steady compound was formed through the interaction of EBS and SAF in the acetic acid buffer system ( pH = 6.5 ) and the interaction could be sensitized by C4. The compound had a maximum absorption at 560 nm and there was a good linear relationship between the absorbance of the compound and a certain concen-tration range of ebastine concentration. Results : The equation of calibration curve was A = 0. 029 + 0. 005 C ( C : μg·mL^-1 ). The range of calibration curve was between 2. 5 and 20. 0 μg·mL^-1 ( r = 0. 9995 ) and the detection limit was 0. 96 μg·mL^-1( S/N = 3 ). The recovery was 96. 1% - 106. 4%. Conclusion: The method is simple, rap-id with good accuracy for determining ebastine.
出处 《药物分析杂志》 CAS CSCD 北大核心 2013年第6期1029-1032,共4页 Chinese Journal of Pharmaceutical Analysis
基金 国家自然科学基金项目资助(项目号21155001)
关键词 依巴斯汀 离子液体 增敏作用 水杨基荧光酮 分光光度法 甲基咪唑四氟硼酸盐 ebastine ionic liquid sensitization salicyl fluorine methylimidazo liumtetrofluoroborate spectrophotom-etry
  • 相关文献

参考文献14

  • 1王娜,肖亚平.第二代H1抗组胺类药物——依巴斯汀[J].化学通报,2008,71(1):40-43. 被引量:4
  • 2Ibrahim F,El-Din MK,Eid Ml,et al. Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparations.Chem Cent J,2011,5(1):11.
  • 3Mohie KS,Fawzia I,et al.Validated spectroflurimetric determination of some H1receptor antagonist drugs in pharmaceutical preparations through charge transfer complexation.J Fluoresc ,2012,22(1):175.
  • 4Kang W,Liu K-H,Ryu J Y,et al.Simultaneous determination of ebastine and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry.J Chromatogr B,2004,813(1-2):75.
  • 5Feng S,Jiang J,Wang P.Simultaneous determination of ebastine and its active metabolite (carebastine) in human plasma Using LC-MS-MS.Chromatographia,2009,70(9-10):1417.
  • 6王传平,孙舒婷,张丽娜,陈欣,魏琴.光度分析法在药物分析中的研究与应用[J].分析测试技术与仪器,2007,13(3):169-173. 被引量:5
  • 7The sface food and drug administation bureau of sfandards(trial) YBH00972004.
  • 8刘志敏,曹艳艳,康小慧.药物酚磺乙胺在MnO_2/离子液体复合电极上的电化学行为研究及测定[J].药物分析杂志,2011,31(6):1171-1174. 被引量:1
  • 9朱占洲,孙青龑,沈颂章,何邦平,王小燕.绿色环保离子液体在药学研究中的应用进展[J].药学实践杂志,2009,27(4):248-250. 被引量:4
  • 10Quijano G,Couvert A,Amrane A.Ionic liquids:applications and future trends in bioreactor technology.Bioresour Technol,2010,101(23):8923.

二级参考文献126

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部